A.I. Software Acquires Patented Stem Cell Expansion Technology
A.I. Software, Inc., has reached an agreement with the Weitzman Institute of Science and Technion — Israel Institute of Technology to acquire the exclusive rights of stem cell expansion technology. Researchers at Israel’s top research institutions have developed a unique advanced technology in its early stages that expands stem cells from umbilical cord blood without Read more about A.I. Software Acquires Patented Stem Cell Expansion Technology[…]